tailieunhanh - Biofilm detection amongst metallo Beta lactamase (MBL) producing clinical isolates of Pseudomonas aeruginosa

In recent decades the global emergence the development of multidrug-resistant and pan drug resistance in Pseudomonas aeruginosa has been observed. This opportunistic pathogen is responsible for causing various infections especially in the intensive care units, resulting for almost 10% of nosocomial infections. The resistance to Metallo betalactamase in P. aeruginosa strains has been related with bacterial biofilm formation. So, the aim of this study was to determine the rates of biofilm production and metallo betalactamase production (MBL) among the strains of Pseudomonas aeruginosa. A total of 200 P. aeruginosa isolates were isolated from different clinical specimens were included in this study. Modified Kirby-Bauer disc diffusion technique was used for antimicrobial susceptibility testing. MBL production was detected by E-Test, while microtiter plate assay was used for detection of biofilm production. Out of 200 isolates, 21 isolates were MBL producing whereas, 32 were able to produce biofilm as shown microtiter plate assay. The highest tendency of biofilm production was shown by Pseudomonas aeruginosa isolated from urine followed endotracheal tube. Highest rates of susceptibility of were seen toward colistin. In our study, biofilm production and metallo betalactamase production were observed among Pseudomonas aeruginosa. However, no statistically significant association could be established between biofilm production and metallo beta-lactamase production. | Biofilm detection amongst metallo Beta lactamase (MBL) producing clinical isolates of Pseudomonas aeruginosa